B-type natriuretic peptide is released by cardiac myocytes in response to wall stretch. There are many hemodynamic effects of BNP which are beneficial in the setting of decompensated congestive heart ...
Nearly 5 million Americans have heart failure (HF). Making a correct diagnosis early is an important component in the multifaceted approach to detection and/or treatment of this disease. The US Food ...
Dublin, May 18, 2023 (GLOBE NEWSWIRE) -- The "Global BNP and NT-proBNP Market Size, Share & Industry Trends Analysis Report by Location of Testing, Application, Regional Outlook and Forecast, ...
In the urgent-care setting, determining the cause of dyspnea has been difficult because traditional, subjective methods of distinguishing heart failure from pulmonary conditions leave a high level of ...
Heart failure has a significant impact on health and its prevalence increases with age (Cowie et al, 1997). Coronary heart disease (CHD) and hypertension are the most common causes (Cowie et al, 1999) ...
This prospective study investigates whether amino terminal proB-type natriuretic peptide (NT-proBNP) levels are elevated in neonates with congenital heart defect (CHD). NT-proBNP levels in the ...
ANP, BNP, and CNP are proving to be reliable biomarkers for a variety of conditions. Natriuretic peptides mainly consist of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and ...
BNP levels in the blood reflects the severity of cardiac dysfunction. Higher BNP levels have been associated with adverse clinical outcomes. This study looked at end-stage heart failure patients with ...
An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback